{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:27Z","timestamp":1786993707134,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["200273"],"award-info":[{"award-number":["200273"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007432","name":"Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["ICR-100-508"],"award-info":[{"award-number":["ICR-100-508"]}],"id":[{"id":"10.13039\/501100007432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015034","name":"Shahid Sadoughi University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118117","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T02:03:06Z","timestamp":1595037786000},"page":"118117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors"],"prefix":"10.1016","volume":"257","author":[{"given":"Sahar","family":"Shariati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Mehdipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Rasolmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol-Rasoul","family":"Talei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118117_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lfs.2020.118117_bb0010","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmentals regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118117_bb0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pages","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118117_bb0020","first-page":"101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"25","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.lfs.2020.118117_bb0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2020.118117_bb0030","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.118117_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2020.118117_bb0040","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2020.118117_bb0045","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.1400336","article-title":"A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production","volume":"193","author":"Kaku","year":"2014","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.lfs.2020.118117_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118117_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/sji.12407","article-title":"Increased B regulatory phenotype in non-metastatic lymph lodes of node-positive breast cancer patients","volume":"83","author":"Mehdipour","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2020.118117_bb0060","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1158\/1078-0432.CCR-11-0207","article-title":"Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression","volume":"17","author":"Li","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118117_bb0065","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","article-title":"Margin-infiltrating CD20+ B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma","volume":"19","author":"Shi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118117_bb0070","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27\u2212 memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118117_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2567.2000.00121.x","article-title":"CD28, CTLA-4 and their ligands: who does what and to whom?","volume":"101","author":"Sansom","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2020.118117_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0092-8674(95)90349-6","article-title":"B7-1 and B7-2 costimulatory molecules activate differentially the Th1\/Th2 developmental pathways: application to autoimmune disease therapy","volume":"80","author":"Kuchroo","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118117_bb0085","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V98.4.1135","article-title":"Th2 polarization by Der p 1\u2014pulsed monocyte-derived dendritic cells is due to the allergic status of the donors","volume":"98","author":"Hammad","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.118117_bb0090","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.160.9.4622","article-title":"Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis","volume":"160","author":"Jirapongsananuruk","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118117_bb0095","doi-asserted-by":"crossref","first-page":"769239","DOI":"10.1155\/2014\/769239","article-title":"CD80 and CD86 costimulatory molecules differentially regulate OT-II CD4+ T lymphocyte proliferation and cytokine response in cocultures with antigen-presenting cells derived from pregnant and pseudopregnant mice","volume":"2014","author":"Maj","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2020.118117_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1075112","article-title":"PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in invasive breast cancer","volume":"5","author":"Guan","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.lfs.2020.118117_bb0105","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.4049\/jimmunol.1502678","article-title":"Regulatory IgDhi B cells suppress T cell function via IL-10 and PD-L1 during progressive visceral Leishmaniasis","volume":"196","author":"Schaut","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118117_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2015.08.004","article-title":"Salmonella induces PD-L1 expression in B cells","volume":"167","author":"Lopez-Medina","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2020.118117_bb0115","doi-asserted-by":"crossref","first-page":"35651","DOI":"10.1038\/srep35651","article-title":"PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer","volume":"6","author":"Guan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118117_bb0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13402-019-00433-3","article-title":"The significance of cytokine-producing B cells in breast tumor-draining lymph nodes","volume":"42","author":"Mehdipour","year":"2019","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.lfs.2020.118117_bb0125","first-page":"108","article-title":"Correlation of 4-1BBL+ B cells in tumor draining lymph nodes with pathological characteristics of breast cancer","volume":"16","author":"Arabpour","year":"2019","journal-title":"Iran. J. Immunol"},{"key":"10.1016\/j.lfs.2020.118117_bb0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.lfs.2020.118117_bb0135","doi-asserted-by":"crossref","first-page":"31347","DOI":"10.18632\/oncotarget.15532","article-title":"Expression of PD-L1 and prognosis in breast cancer: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118117_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1320011","article-title":"CD39\/CD73 upregulation on myeloid-derived suppressor cells via TGF-beta-mTOR-HIF-1 signaling in patients with non-small cell lung cancer","volume":"6","author":"Li","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lfs.2020.118117_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2013-02-482406","article-title":"Adenosine production by human B cells and B cell-mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.118117_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-12-134","article-title":"Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers","volume":"12","author":"Droeser","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2020.118117_bb0155","first-page":"3","article-title":"Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast","volume":"10","author":"Lim","year":"2010","journal-title":"Cancer Immun. Arch."},{"key":"10.1016\/j.lfs.2020.118117_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00428-004-1143-9","article-title":"Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast","volume":"446","author":"Kuroda","year":"2005","journal-title":"Virch. Arch"},{"key":"10.1016\/j.lfs.2020.118117_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2019.07.019","article-title":"Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes","volume":"114","author":"Arabpour","year":"2019","journal-title":"Mol. Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:21:31Z","timestamp":1765228891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"alternative-id":["S0024320520308687"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118117","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118117"}}